BSE filing, NSE: ISHITADR. Summary written from the filing by ALFA Finder's alert engine.
Ishita Drugs & Industries Ltd: key numbers
- Share price
- ₹73.80
- Market cap
- ₹22.07 Cr
- Revenue (annual)
- ₹14.66 Cr
- Net profit (annual)
- ₹0.78 Cr
- P/E (TTM)
- 31.2×Sector 46.1×
- Promoter holding
- 50.04%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ishita Drugs & Industries Ltd
All →Ishita Drugs & Industries Board Meeting Date
Ishita Drugs & Industries will hold a board meeting on 03/11/2026 to approve Q1 FY2027 unaudited results. The filing is a prior intimation under Regulation 29 of SEBI LODR.
Ishita Drugs & Industries Other Announcement
Ishita Drugs & Industries Ltd submitted its quarterly shareholding pattern under Regulation 31, disclosing the promoter and public shareholdings as of September 30, 2026.
Ishita Drugs & Industries Other Announcement
Ishita Drugs & Industries Ltd has re-appointed M/s. Jaymin Shah & Associates as its Statutory Auditor from the 33rd to the 34th AGM.
Ishita Drugs & Industries Annual General Meeting
Ishita Drugs & Industries Ltd. held its 33rd Annual General Meeting on September 30, 2026. The meeting covered financial statements, auditor appointments, and director re-appointment.
Ishita Drugs & Industries Debt & Borrowing: ₹11.75 Cr
Ishita Drugs approved Rs.11.75 Crore borrowings from HDFC Bank, covering a term loan and working capital facility. This is within shareholder-approved borrowing limits from its 31st AGM.
- Value
- ₹11.75 Cr
Ishita Drugs & Industries Board Meeting Date
Ishita Drugs & Industries Ltd will hold a board meeting on September 22, 2026. The meeting will consider raising funds through working capital and term loans.
Other management change announcements
All →Srivasavi Adhesive Tapes Management Change
Srivasavi Adhesive Tapes appointed Ms. Venugopal as Chief Financial Officer effective 29 October 2026. She holds an MBA in Finance with seven years of finance experience.
Restaurant Brands Asia Management Change
Restaurant Brands Asia appointed nine persons on October 29, 2026, including two directors, a CEO and senior management heads. Shivkumar Dega joins as a non-executive independent director.
Asset Reconstruction Company (India) Management Change
ARCIL re-appointed Balachander Rajaraman as independent director for 36 months and appointed Sanjay Vasarkar as senior management personnel. Deloitte was also re-appointed as internal auditor.
- Execution
- 36 months (director re-appointment term)
Capital Small Finance Bank Management Change
Capital Small Finance Bank's board approved two independent director appointments pending shareholder approval. Joseph D'souza is regularised and Nageswara Rao Yalamanchili reappointed.
- Execution
- Joseph Conrad Agnelo D'souza: 5 years from September 28, 2026. Nageswara Rao Yalamanchili: 3 consecutive years from June 29, 2027.
GVP Infotech Management Change
GVP Infotech reported the resignation of Company Secretary and Compliance Officer Abhilasha Ghumelia, effective October 31, 2026. She cited a better career opportunity, with no other material reasons.
Padmanabh Industries Management Change
Padmanabh Industries' board appointed a new CFO and an independent director, and accepted the resignations of an independent director and the former CFO, all effective 30 October 2026. Committees were also reconstituted.